Literature DB >> 22622634

Therapeutics: iterations of BRAF.

Gemma K Alderton.   

Abstract

Entities:  

Year:  2012        PMID： 22622634     DOI： 10.1038/nrc3284

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling.

Authors:  Michael Röring; Ricarda Herr; Gina J Fiala; Katharina Heilmann; Sandra Braun; Anja E Eisenhardt; Sebastian Halbach; David Capper; Andreas von Deimling; Wolfgang W Schamel; Darren N Saunders; Tilman Brummer
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.